Evaluation of the hypercoagulable state - Whom to screen, how to test and treat

被引：13

作者：

Barger, AP

Hurley, R

机构：

[1] Reg Hosp, Dept Internal Med, St Paul, MN 55101 USA

[2] Univ Minnesota, Sch Med, Div Hematol Oncol, Minneapolis, MN 55455 USA

[3] Reg Hosp, Dept Hematol Oncol, St Paul, MN 55101 USA

来源：

POSTGRADUATE MEDICINE | 2000年 / 108卷 / 04期

关键词：

D O I：

10.3810/pgm.2000.09.15.1236

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

As new inherited and acquired prothrombotic abnormalities have been discovered, our knowledge about the mechanisms of venous thrombosis has advanced. However, questions about whom to screen and how to manage remain. Dr Barger and Dr Hurley discuss the inherited and acquired causes of thrombosis, describe an approach to risk assessment and laboratory evaluation, and present general guidelines for management.

引用

收藏

页码：59 / 66

页数：8

相关论文

共 22 条

[1]

BAUER KA, 1999, AM SOC HEMATOLOGY ED, P231

[2]

BAUER KA, 1998, AM SOC HEMATOLOG DEC, P255

[3] Hereditary and acquired thrombophilia - Part I - Preface [J].

Bick, RL .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1999, 25 (03) :251-253

[4] Syndromes of thrombosis and hypercoagulability - Congenital and acquired causes of thrombosis [J].

Bick, RL ;

Kaplan, H .

MEDICAL CLINICS OF NORTH AMERICA, 1998, 82 (03) :409-+

[5] Importance of findings on the initial evaluation for cancer in patients with symptomatic idiopathic deep venous thrombosis [J].

Cornuz, J ;

Pearson, SD ;

Creager, MA ;

Cook, EF ;

Goldman, L .

ANNALS OF INTERNAL MEDICINE, 1996, 125 (10) :785-+

[6] The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation [J].

De Stefano, V ;

Martinelli, I ;

Mannucci, PM ;

Paciaroni, K ;

Chiusolo, P ;

Casorelli, I ;

Rossi, E ;

Leone, G .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (11) :801-806

[7] Oral anticoagulant therapy for venous thromboembolism [J].

Diuguid, DL .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (06) :433-434

[8] Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. [J].

Gerhardt, A ;

Scharf, RE ;

Beckmann, MW ;

Struve, S ;

Bender, HG ;

Pillny, M ;

Sandmann, W ;

Zotz, RB .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (06) :374-380

[9] ANTIPHOSPHOLIPID ANTIBODIES AND VENOUS THROMBOEMBOLISM [J].

GINSBERG, JS ;

WELLS, PS ;

BRILLEDWARDS, P ;

DONOVAN, D ;

MOFFATT, K ;

JOHNSTON, M ;

STEVENS, P ;

HIRSH, J .

BLOOD, 1995, 86 (10) :3685-3691

[10] A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism [J].

Kearon, C ;

Gent, M ;

Hirsh, J ;

Weitz, J ;

Kovacs, MJ ;

Anderson, DR ;

Turpie, AG ;

Green, D ;

Ginsberg, JS ;

Wells, P ;

MacKinnon, B ;

Julian, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (12) :901-907